Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

Por Ohnishi, Kazunori, Nakaseko, Chiaki, Takeuchi, Jin, Fujisawa, Shin, Nagai, Tadashi, Yamazaki, Hirohito, Tauchi, Tetsuzo, Imai, Kiyotoshi, Mori, Naoki, Yagasaki, Fumiharu, Maeda, Yasuhiro, Usui, Noriko, Miyazaki, Yasushi, Miyamura, Koichi, Kiyoi, Hitoshi, Ohtake, Shigeki, Naoe, Tomoki
Publicado no Cancer Sci (2012)

Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation

Por Nicolini, Franck E., Mauro, Michael J., Martinelli, Giovanni, Kim, Dong-Wook, Soverini, Simona, Müller, Martin C., Hochhaus, Andreas, Cortes, Jorge, Chuah, Charles, Dufva, Inge H., Apperley, Jane F., Yagasaki, Fumiharu, Pearson, Jay D., Peter, Senaka, Sanz Rodriguez, Cesar, Preudhomme, Claude, Giles, Francis, Goldman, John M., Zhou, Wei
Publicado no Blood (2009)